[go: up one dir, main page]

FR3010188B1 - THERAGNOSTIC PROCESS FOR THE TREATMENT OF CHRONIC INFLAMMATORY RHUMATISMS - Google Patents

THERAGNOSTIC PROCESS FOR THE TREATMENT OF CHRONIC INFLAMMATORY RHUMATISMS

Info

Publication number
FR3010188B1
FR3010188B1 FR1358503A FR1358503A FR3010188B1 FR 3010188 B1 FR3010188 B1 FR 3010188B1 FR 1358503 A FR1358503 A FR 1358503A FR 1358503 A FR1358503 A FR 1358503A FR 3010188 B1 FR3010188 B1 FR 3010188B1
Authority
FR
France
Prior art keywords
rhumatisms
theragnostic
treatment
chronic inflammatory
chronic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1358503A
Other languages
French (fr)
Other versions
FR3010188A1 (en
Inventor
Philippe Gaudin
Francoise Morel
Candice Trocme
Jean-Francois Robineau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sinnovial Fr
Centre Hospitalier Universitaire de Grenoble
Universite Grenoble Alpes
Original Assignee
KOWOK THERAGNOSTIC
Universite Joseph Fourier Grenoble 1
Centre Hospitalier Universitaire de Grenoble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KOWOK THERAGNOSTIC, Universite Joseph Fourier Grenoble 1, Centre Hospitalier Universitaire de Grenoble filed Critical KOWOK THERAGNOSTIC
Priority to FR1358503A priority Critical patent/FR3010188B1/en
Publication of FR3010188A1 publication Critical patent/FR3010188A1/en
Application granted granted Critical
Publication of FR3010188B1 publication Critical patent/FR3010188B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rehabilitation Therapy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
FR1358503A 2013-09-05 2013-09-05 THERAGNOSTIC PROCESS FOR THE TREATMENT OF CHRONIC INFLAMMATORY RHUMATISMS Expired - Fee Related FR3010188B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1358503A FR3010188B1 (en) 2013-09-05 2013-09-05 THERAGNOSTIC PROCESS FOR THE TREATMENT OF CHRONIC INFLAMMATORY RHUMATISMS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1358503A FR3010188B1 (en) 2013-09-05 2013-09-05 THERAGNOSTIC PROCESS FOR THE TREATMENT OF CHRONIC INFLAMMATORY RHUMATISMS

Publications (2)

Publication Number Publication Date
FR3010188A1 FR3010188A1 (en) 2015-03-06
FR3010188B1 true FR3010188B1 (en) 2017-11-24

Family

ID=49816952

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1358503A Expired - Fee Related FR3010188B1 (en) 2013-09-05 2013-09-05 THERAGNOSTIC PROCESS FOR THE TREATMENT OF CHRONIC INFLAMMATORY RHUMATISMS

Country Status (1)

Country Link
FR (1) FR3010188B1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11579145B2 (en) * 2016-10-17 2023-02-14 Reliant Immune Diagnostics, Inc. System and method for image analysis of medical test results
US11651866B2 (en) 2016-10-17 2023-05-16 Reliant Immune Diagnostics, Inc. System and method for real-time insurance quote in response to a self-diagnostic test
US12009078B2 (en) 2016-10-17 2024-06-11 Reliant Immune Diagnostics, Inc. System and method for medical escalation and intervention that is a direct result of a remote diagnostic test
US11693002B2 (en) 2016-10-17 2023-07-04 Reliant Immune Diagnostics, Inc. System and method for variable function mobile application for providing medical test results using visual indicia to determine medical test function type
US10902951B2 (en) 2016-10-17 2021-01-26 Reliant Immune Diagnostics, Inc. System and method for machine learning application for providing medical test results using visual indicia
US11802868B2 (en) 2016-10-17 2023-10-31 Reliant Immune Diagnostics, Inc. System and method for variable function mobile application for providing medical test results
US9857372B1 (en) 2016-10-17 2018-01-02 Reliant Immune Diagnostics, LLC Arbovirus indicative birth defect risk test
US11107585B2 (en) 2016-10-17 2021-08-31 Reliant Immune Diagnostics, Inc System and method for a digital consumer medical wallet and storehouse

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120178100A1 (en) * 2009-07-28 2012-07-12 Centocor Ortho Biotech Inc. Serum Markers Predicting Clinical Response to Anti-TNF Alpha Antibodies in Patients with Psoriatic Arthritis
CN103797131A (en) * 2011-06-16 2014-05-14 卡里斯生命科学卢森堡控股有限责任公司 Biomarker compositions and methods

Also Published As

Publication number Publication date
FR3010188A1 (en) 2015-03-06

Similar Documents

Publication Publication Date Title
EP3397963A4 (en) INHIBITION OF P38 MAPK FOR THE TREATMENT OF CANCER
MA39748A (en) CENICRIVIROC FOR THE TREATMENT OF FIBROSIS
EP3011515A4 (en) TREATMENT OF VOICE TRANSACTIONS
EP2956101A4 (en) DRESSING FOR WOUND TREATMENT
MA41449A (en) POLYTHERAPIES FOR THE TREATMENT OF CANCERS
EP2967819A4 (en) METHODS AND DEVICES FOR URETRAL TREATMENT
MA41555A (en) POLYTHERAPY FOR CANCER TREATMENT
FR3010188B1 (en) THERAGNOSTIC PROCESS FOR THE TREATMENT OF CHRONIC INFLAMMATORY RHUMATISMS
EP3389645A4 (en) COMBINATIONS FOR THE TREATMENT OF CANCER
EP3359255A4 (en) POLYTHERAPIES FOR THE TREATMENT OF CANCER
MA45429A (en) POLYTHERAPY FOR CANCER TREATMENT
EP2991673A4 (en) INJECTABLE NANORESIN GELS FOR THE TREATMENT OF DIABETES
MA42999A (en) POLYTHERAPY FOR THE TREATMENT OF MALIGNITIES
EP3455188C0 (en) SLAG TREATMENT PROCESS
EP3335041A4 (en) BIOMARKERS FOR THE TREATMENT OF PELADE
MA41123A (en) POLYTHERAPY FOR CANCER TREATMENT
EP3334432A4 (en) CERDULATINIB FOR THE TREATMENT OF MYELOMA
FR20C1044I2 (en) TRIAZINES FOR THE TREATMENT OF PROTOZOIC INFECTIONS
HUE046508T2 (en) Orvepitant for the treatment of chronic itching
EP2950798A4 (en) PPAR AGONISTS FOR THE TREATMENT OF MULTIPLE SCLEROSIS
EP3316887A4 (en) GLS1 INHIBITORS FOR THE TREATMENT OF DISEASES
EP2968478A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARBOXYHEMOGLOBINEMIA
EP2986120A4 (en) METHYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF CANCER
EP2970975A4 (en) TARGETING CHROMATIN MODIFIERS FOR THE TREATMENT OF PATHOLOGIES
EP2886122A4 (en) AGENT FOR THE TREATMENT OF CANCER

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

TQ Partial transmission of property

Owner name: UNIVERSITE JOSEPH FOURIER - GRENOBLE 1, FR

Effective date: 20180924

Owner name: SINNOVIAL, FR

Effective date: 20180924

Owner name: CENTRE HOSPITALIER UNIVERSITAIRE GRENOBLE, FR

Effective date: 20180924

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

TQ Partial transmission of property

Owner name: UNIVERSITE GRENOBLE ALPES, FR

Effective date: 20230130

Owner name: SINNOVIAL, FR

Effective date: 20230130

Owner name: CENTRE HOSPITALIER UNIVERSITAIRE GRENOBLE, FR

Effective date: 20230130

ST Notification of lapse

Effective date: 20230505